Gene therapy takes on Hard-to-Treat kidney cancer
Disease control
Terminated
This study tested a single dose of Temferon, a gene therapy made from a patient's own blood stem cells, in 10 people with advanced kidney cancer that had worsened after at least two standard treatments. The goal was to see if it was safe and could trigger an immune response in th…
Phase: PHASE1, PHASE2 • Sponsor: Genenta Science • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC